CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +1,690,700 | 1,690,700 | ||
| 2025-12-22 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +2,250,000 | 2,250,000 | ||
| 2024-12-05 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2023-10-04 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +100,450 | 100,450 | ||
| 2023-05-02 | Luthringer Remy CEO | Sale | −3,641 | $3.76 | $14K | 68,994 |
| 2023-05-01 | Luthringer Remy CEO | Sale | −23,753 | $3.85 | $91K | 72,635 |
| 2023-04-28 | Luthringer Remy CEO | Grant or award | +88,077 | 96,388 | ||
| 2022-12-13 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-02-16 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +505,000 | 505,000 | ||
| 2020-12-16 | Luthringer Remy CEO | Sale | −1,300 | $2.64 | $3K | 66,490 |
| 2020-12-14 | Luthringer Remy CEO | Option exercise | +18,750 | 67,790 | ||
| 2020-12-14 | Luthringer Remy CEO | Option exercise · Restricted Stock Unit | −18,750 | 0 | ||
| 2020-10-13 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-06-19 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +354,302 | 354,302 | ||
| 2019-12-31 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +95,698 | 95,698 | ||
| 2019-12-17 | Luthringer Remy CEO | Sale | −2,412 | $7.10 | $17K | 49,040 |
| 2019-12-14 | Luthringer Remy CEO | Option exercise | +18,750 | 51,452 | ||
| 2019-12-14 | Luthringer Remy CEO | Option exercise · Restricted Stock Unit | −18,750 | 18,750 | ||
| 2018-12-17 | Luthringer Remy CEO | Sale | −2,604 | $7.46 | $19K | 32,702 |
| 2018-12-14 | Luthringer Remy CEO | Option exercise | +18,750 | 35,306 |
Page 1 of 2 · 36 trades